Kwality Pharmaceuticals Limited Share Price & Analysis
₹2,371.4▼ -0.16%Updated 5 Jun 2026, 05:02 pm IST
LTP
₹2,371.4
-0.16%
Open
₹—
High
₹2,440
Low
₹2,331.1
Close
₹2,371.4
52W High
₹2,390
52W Low
₹829
Volume
22K
Lot Size
1
Sector
Healthcare
Market Cap
₹2K Cr
Face Value
₹10
Small Cap
Price Chart
Fundamentals
P/E
35.1
Sector P/E
48.9
P/B
7.41
EPS
₹54.5
ROE
22.8%
ROCE
24.2%
D/E Ratio
0.39
Div Yield
0%
Book Value
₹320
+
Strengths
- ✓Excellent return on equity (ROE 22.8%)
- ✓Efficient capital deployment (ROCE 24.2%)
- ✓Attractively valued vs sector (P/E 35.1x vs industry 48.9x)
- ✓Low debt relative to equity (D/E 0.4x)
−
Concerns
- ✗Trading near 52-week high (₹2,390)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,783 | ₹4.3L Cr | 34.4 | 5.12 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,616 | ₹1.7L Cr | 66.1 | 10.48 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,416 | ₹1.5L Cr | 66.4 | 17.81 | 27.6 | 15.4 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,315 | ₹1.2L Cr | 59.5 | 12.62 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,402 | ₹1.1L Cr | 27.3 | 3.29 | 12.4 | 16.6 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,091 | ₹1.1L Cr | 20 | 4.05 | 21.2 | 21.2 | 0.38 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,283 | ₹1.1L Cr | 25.4 | 2.83 | 11.8 | 13.6 | 0.16 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
KPL · as of Mar 2026
Promoters54.82%
DII0.32%▲0.29
Public44.86%▼0.28
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 54.76% | 54.82% | 54.82% | 54.82% | 54.82% | 54.82% |
| DII | 0.01% | — | — | 0.02% | 0.03% | 0.32% |
| Public | 45.22% | 45.17% | 45.18% | 45.15% | 45.14% | 44.86% |
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹123 Cr ▲10.8% | ₹111 Cr ▲0.0% | ₹111 Cr ▼4.3% | ₹116 Cr ▲38.1% | ₹84 Cr ▼6.7% | ₹90 Cr ▲12.5% | ₹80 Cr ▼13.0% | ₹92 Cr |
| Op. Profit | ₹30 Cr ▲20.0% | ₹25 Cr ▲4.2% | ₹24 Cr ▼7.7% | ₹26 Cr ▲44.4% | ₹18 Cr ▼10.0% | ₹20 Cr ▲17.6% | ₹17 Cr ▼19.0% | ₹21 Cr |
| OPM | 24.0% ▲4.3% | 23.0% ▲4.5% | 22.0% ▲0.0% | 22.0% ▲4.8% | 21.0% ▼4.5% | 22.0% ▲0.0% | 22.0% ▲0.0% | 22.0% |
| Net Profit | ₹16 Cr ▲14.3% | ₹14 Cr ▲16.7% | ₹12 Cr ▼14.3% | ₹14 Cr ▲55.6% | ₹9 Cr ▲12.5% | ₹8 Cr ▲0.0% | ₹8 Cr ▲100.0% | ₹4 Cr |
| EPS (₹) | 15.43 ▲13.4% | 13.61 ▲18.3% | 11.5 ▼17.6% | 13.96 ▲69.8% | 8.22 ▲0.7% | 8.16 ▲1.2% | 8.06 ▲91.9% | 4.2 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹503 Cr ▲35.9% | ₹370 Cr ▲20.5% | ₹307 Cr ▲22.3% | ₹251 Cr ▼45.0% | ₹456 Cr ▲74.0% | ₹262 Cr ▲88.5% | ₹139 Cr ▼16.3% | ₹166 Cr ▲21.2% | ₹137 Cr ▲39.8% | ₹98 Cr |
| Expenses | ₹385 Cr ▲32.8% | ₹290 Cr ▲20.3% | ₹241 Cr ▲26.8% | ₹190 Cr ▼33.3% | ₹285 Cr ▲22.3% | ₹233 Cr ▲86.4% | ₹125 Cr ▼16.7% | ₹150 Cr ▲19.0% | ₹126 Cr ▲41.6% | ₹89 Cr |
| Op. Profit | ₹118 Cr ▲47.5% | ₹80 Cr ▲21.2% | ₹66 Cr ▲8.2% | ₹61 Cr ▼64.5% | ₹172 Cr ▲493.1% | ₹29 Cr ▲107.1% | ₹14 Cr ▼12.5% | ₹16 Cr ▲33.3% | ₹12 Cr ▲33.3% | ₹9 Cr |
| OPM | 24.0% ▲9.1% | 22.0% ▲0.0% | 22.0% ▼8.3% | 24.0% ▼36.8% | 38.0% ▲245.5% | 11.0% ▲10.0% | 10.0% ▲11.1% | 9.0% ▲12.5% | 8.0% ▼11.1% | 9.0% |
| Other Income | ₹2 Cr ▲0.0% | ₹2 Cr ▲140.0% | ₹-5 Cr ▲64.3% | ₹-14 Cr ▼450.0% | ₹4 Cr ▲100.0% | ₹2 Cr ▼50.0% | ₹4 Cr ▲300.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▲0.0% | ₹1 Cr |
| Interest | ₹11 Cr ▲10.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲42.9% | ₹7 Cr ▲133.3% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▲50.0% | ₹2 Cr ▲0.0% | ₹2 Cr ▲0.0% | ₹2 Cr |
| Depreciation | ₹20 Cr ▲11.1% | ₹18 Cr ▼10.0% | ₹20 Cr ▲33.3% | ₹15 Cr ▲36.4% | ₹11 Cr ▲83.3% | ₹6 Cr ▲50.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr |
| PBT | ₹89 Cr ▲64.8% | ₹54 Cr ▲74.2% | ₹31 Cr ▲19.2% | ₹26 Cr ▼84.0% | ₹162 Cr ▲671.4% | ₹21 Cr ▲90.9% | ₹11 Cr ▲0.0% | ₹11 Cr ▲57.1% | ₹7 Cr ▲16.7% | ₹6 Cr |
| Tax % | 25.0% ▼3.8% | 26.0% ▲8.3% | 24.0% ▼4.0% | 25.0% ▼3.8% | 26.0% ▼13.3% | 30.0% ▲20.0% | 25.0% ▼19.4% | 31.0% ▼20.5% | 39.0% ▼7.1% | 42.0% |
| Net Profit | ₹67 Cr ▲67.5% | ₹40 Cr ▲66.7% | ₹24 Cr ▲26.3% | ₹19 Cr ▼84.2% | ₹120 Cr ▲700.0% | ₹15 Cr ▲87.5% | ₹8 Cr ▲0.0% | ₹8 Cr ▲100.0% | ₹4 Cr ▲33.3% | ₹3 Cr |
| EPS (₹) | 64.91 ▲69.0% | 38.41 ▲67.4% | 22.94 ▲22.9% | 18.67 ▼83.9% | 115.64 ▲692.1% | 14.6 ▲82.0% | 8.02 ▲10.2% | 7.28 ▲65.8% | 4.39 ▲35.9% | 3.23 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% ▼100.0% | 9.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲100.0% | ₹5 Cr |
| Reserves | ₹280 Cr ▲10.2% | ₹254 Cr ▲18.7% | ₹214 Cr ▲12.6% | ₹190 Cr ▲11.1% | ₹171 Cr ▲235.3% | ₹51 Cr ▲41.7% | ₹36 Cr ▲33.3% | ₹27 Cr ▲42.1% | ₹19 Cr ▼5.0% | ₹20 Cr |
| Borrowings | ₹110 Cr ▼1.8% | ₹112 Cr ▲14.3% | ₹98 Cr ▲8.9% | ₹90 Cr ▲66.7% | ₹54 Cr ▲31.7% | ₹41 Cr ▲17.1% | ₹35 Cr ▲20.7% | ₹29 Cr ▲11.5% | ₹26 Cr ▲36.8% | ₹19 Cr |
| Other Liabilities | ₹77 Cr ▲8.5% | ₹71 Cr ▼1.4% | ₹72 Cr ▲2.9% | ₹70 Cr ▼33.3% | ₹105 Cr ▲64.1% | ₹64 Cr ▲23.1% | ₹52 Cr ▲33.3% | ₹39 Cr ▼2.5% | ₹40 Cr ▲53.8% | ₹26 Cr |
| Total Liabilities | ₹478 Cr ▲6.9% | ₹447 Cr ▲13.5% | ₹394 Cr ▲9.1% | ₹361 Cr ▲5.9% | ₹341 Cr ▲105.4% | ₹166 Cr ▲24.8% | ₹133 Cr ▲26.7% | ₹105 Cr ▲9.4% | ₹96 Cr ▲35.2% | ₹71 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹144 Cr ▼1.4% | ₹146 Cr ▲5.0% | ₹139 Cr ▲15.8% | ₹120 Cr ▲30.4% | ₹92 Cr ▲61.4% | ₹57 Cr ▲32.6% | ₹43 Cr ▲48.3% | ₹29 Cr ▲45.0% | ₹20 Cr ▲17.6% | ₹17 Cr |
| CWIP | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹14 Cr ▲16.7% | ₹12 Cr ▲300.0% | ₹3 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr ▼100.0% | ₹5 Cr ▲25.0% | ₹4 Cr ▼20.0% | ₹5 Cr ▲0.0% | ₹5 Cr ▲25.0% | ₹4 Cr |
| Other Assets | ₹334 Cr ▲10.6% | ₹302 Cr ▲18.4% | ₹255 Cr ▲12.8% | ₹226 Cr ▼4.6% | ₹237 Cr ▲132.4% | ₹102 Cr ▲18.6% | ₹86 Cr ▲21.1% | ₹71 Cr ▲1.4% | ₹70 Cr ▲40.0% | ₹50 Cr |
| Total Assets | ₹478 Cr ▲6.9% | ₹447 Cr ▲13.5% | ₹394 Cr ▲9.1% | ₹361 Cr ▲5.9% | ₹341 Cr ▲105.4% | ₹166 Cr ▲24.8% | ₹133 Cr ▲26.7% | ₹105 Cr ▲9.4% | ₹96 Cr ▲35.2% | ₹71 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹53 Cr ▲23.3% | ₹43 Cr ▲4.9% | ₹41 Cr ▼32.8% | ₹61 Cr ▲125.9% | ₹27 Cr ▲350.0% | ₹6 Cr ▼57.1% | ₹14 Cr ▲1500.0% | ₹-1 Cr ▼125.0% | ₹4 Cr ▲233.3% | ₹-3 Cr |
| Investing CF | ₹-29 Cr ▼11.5% | ₹-26 Cr ▲45.8% | ₹-48 Cr ▲23.8% | ₹-63 Cr ▼173.9% | ₹-23 Cr ▼27.8% | ₹-18 Cr ▼50.0% | ₹-12 Cr ▼100.0% | ₹-6 Cr ▲14.3% | ₹-7 Cr ▼250.0% | ₹-2 Cr |
| Financing CF | ₹-14 Cr ▲17.6% | ₹-17 Cr ▼1800.0% | ₹1 Cr ▼83.3% | ₹6 Cr ▲500.0% | ₹1 Cr ▼91.7% | ₹12 Cr ▲700.0% | ₹-2 Cr ▼140.0% | ₹5 Cr ▲0.0% | ₹5 Cr ▼16.7% | ₹6 Cr |
| Net Cash Flow | ₹10 Cr ▲1100.0% | ₹-1 Cr ▲83.3% | ₹-6 Cr ▼300.0% | ₹3 Cr ▼25.0% | ₹4 Cr | ₹0 Cr | ₹0 Cr ▲100.0% | ₹-1 Cr ▼150.0% | ₹2 Cr | ₹0 Cr |
| Free Cash Flow | ₹28 Cr ▲64.7% | ₹17 Cr ▲525.0% | ₹-4 Cr ▼180.0% | ₹5 Cr ▲66.7% | ₹3 Cr ▲125.0% | ₹-12 Cr ▼700.0% | ₹2 Cr ▲128.6% | ₹-7 Cr ▼250.0% | ₹-2 Cr ▲60.0% | ₹-5 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 152d ▲11.8% | 136d ▲30.8% | 104d ▲89.1% | 55d ▲10.0% | 50d ▼36.7% | 79d ▼6.0% | 84d ▼14.3% | 98d ▲16.7% | 84d ▼5.6% | 89d |
| Inventory Days | 167d ▼10.7% | 187d ▼39.7% | 310d ▲219.6% | 97d ▲155.3% | 38d ▼59.6% | 94d ▲176.5% | 34d ▼37.0% | 54d ▼23.9% | 71d ▲6.0% | 67d |
| Days Payable | 112d ▲5.7% | 106d ▼9.4% | 117d ▲85.7% | 63d ▲8.6% | 58d ▼39.6% | 96d ▲84.6% | 52d ▼35.0% | 80d ▲23.1% | 65d ▲3.2% | 63d |
| Cash Conv. Cycle | 208d ▼4.1% | 217d ▼26.9% | 297d ▲230.0% | 90d ▲200.0% | 30d ▼61.0% | 77d ▲14.9% | 67d ▼8.2% | 73d ▼18.9% | 90d ▼3.2% | 93d |
| Working Capital Days | 98d ▼3.0% | 101d ▼14.4% | 118d ▲96.7% | 60d ▲150.0% | 24d ▼44.2% | 43d ▲115.0% | 20d ▲11.1% | 18d ▼10.0% | 20d ▼51.2% | 41d |
| ROCE | 18.0% ▲12.5% | 16.0% ▼15.8% | 19.0% ▼80.6% | 98.0% ▲276.9% | 26.0% ▲44.4% | 18.0% ▼18.2% | 22.0% ▲15.8% | 19.0% ▲0.0% | 19.0% ▲46.2% | 13.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Kwality Pharmaceuticals Limited share price today?▾
Kwality Pharmaceuticals Limited (KPL) is currently trading at ₹2,371.4 on NSE, down 0.16% as of the last market session. Prices update daily after market close on MarketNetra.
Is Kwality Pharmaceuticals Limited available in F&O (Futures & Options)?▾
Yes, Kwality Pharmaceuticals Limited (KPL) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Kwality Pharmaceuticals Limited 52-week high and low?▾
Kwality Pharmaceuticals Limited's 52-week high is ₹2,390 and the 52-week low is ₹829. The current price of ₹2,371.4 is 0.8% below the 52W high.
What is Kwality Pharmaceuticals Limited P/E ratio?▾
Kwality Pharmaceuticals Limited's current P/E ratio is 35.1. This indicates the market is paying ₹35.1 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Kwality Pharmaceuticals Limited options?▾
Kwality Pharmaceuticals Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade KPL options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.